Compare Ginkgo Bioworks Holdings Inc (DNA) vs Williams-Sonoma, Inc. (WSM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ginkgo Bioworks Holdings Inc vs Williams-Sonoma, Inc. — how do they compare? Ginkgo Bioworks Holdings Inc trades at $13 (market cap $763.64M), while Williams-Sonoma, Inc. trades at $241.78 (market cap $28.15B). The key difference: Williams-Sonoma, Inc. is far larger — about 36.9× Ginkgo Bioworks Holdings Inc's market cap, and Williams-Sonoma, Inc. pays a 1.27% dividend while Ginkgo Bioworks Holdings Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Ginkgo Bioworks Holdings Inc for 7 Days and Williams-Sonoma, Inc. for 59 Days on average.
| DNA | WSM | |
|---|---|---|
Market Cap | $763.64M | $28.15B |
Volume | 3,204,177 | 1,351,262 |
Sector | Health | Consumer Cyclical |
52-Week High | $15.83 | $251.81 |
52-Week Low | $5.48 | $168.64 |
Typical Hold Time | 7 Days | 59 Days |
Enterprise Value | $865.59M | $28.65B |
Dividend Yield | — | 1.27% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Ginkgo Bioworks (DNA) trades at $13.00, up 13.34% today, with a bullish technical signal from moving averages. The company shows strong gross margins of 68.04% but remains unprofitable with a -219.6% net margin. Recent news includes a $17.5M ARPA-H subcontract for RNA medicine manufacturing and partnership expansions, though revenue declined to $132M in 2026.
DNA presents high risk with significant losses and cash burn, but analyst sentiment is divided with equal buy/sell ratings. Investment appeal hinges on future profitability from recent partnerships and government contracts, while current financials and negative cash flow pose substantial downside risk.
Williams-Sonoma (WSM) trades at $239.00, down 0.61% on the day, near its pivot point of $239 with bullish moving average signals. The company demonstrates strong profitability with a 14.73% net income margin and 54.96% ROE, supported by three consecutive quarterly earnings beats. Recent news highlights market share gains and margin expansion through reduced discounting, with a new Pottery Barn collaboration and store openings fueling growth.
The outlook remains positive with a consensus price target of $246.31 offering 3% upside, though risks include housing market sensitivity and high valuation multiples. Earnings growth and disciplined cost control position WSM for continued outperformance, but investors should monitor competitive pressures and macroeconomic headwinds affecting consumer spending.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Ginkgo Bioworks Holdings Inc
Ginkgo Bioworks is a leading horizontal platform for cell programming. It uses advanced automation and software to design custom organisms for customers across diverse industries, including food, agriculture, and pharma.
Read more on DNA →About Williams-Sonoma, Inc.
With a wide retail and direct-to-consumer presence, Williams-Sonoma is a leader in the $300 billion domestic home category, focused on expanding its exposure in the B2B, marketplace, and franchise areas. Namesake Williams-Sonoma (175 stores) offers high-end cooking essentials, while Pottery Barn (189) provides casual home accessories. Brand extensions include Pottery Barn Kids (52) and PBteen. West Elm (121) is an emerging concept for young professionals, and Rejuvenation (9) offers lighting and house parts. Williams-Sonoma also has a business-to-business team that supports projects that range from residential to large-scale commercial.
Read more on WSM →
